|4Mar 31, 8:31 AM ET

Dawson Michael John 4

4 · PALISADE BIO, INC. · Filed Mar 31, 2022

Insider Transaction Report

Form 4
Period: 2022-03-29
Dawson Michael John
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-03-29$1.14/sh+15,000$17,09315,000 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION